Seeking Alpha

Thinly traded Chembio Diagnostics (CEMI +4.2%) promptly erases a 1.6% decline after SA Pro...

Thinly traded Chembio Diagnostics (CEMI +4.2%) promptly erases a 1.6% decline after SA Pro contributor Paul Nouri's article comes out of embargo. Nouri says the company could earn $0.45/share by 2015.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector